US Stock MarketDetailed Quotes

PDSB PDS Biotechnology

Watchlist

3.590
-0.020-0.55%

Trading May 2 12:06 ET

131.68MMarket Cap-2582P/E (TTM)

PDS Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-30.83%-33.64M

-12.33%-8.46M

-21.77%-7.18M

18.66%-4.81M

-107.08%-13.19M

-105.91%-25.71M

-67.26%-7.53M

-14.90%-5.89M

-725.52%-5.92M

-67.51%-6.37M

Net income from continuing operations

-5.11%-42.94M

43.05%-10.9M

-46.13%-10.85M

-98.22%-11.53M

-14.00%-9.66M

-141.48%-40.85M

-202.81%-19.14M

-6.66%-7.42M

-888.10%-5.82M

-177.95%-8.47M

Depreciation and amortization

20,084.88%17.36K

--4.74K

--4.73K

--4.74K

3,568.60%3.16K

-98.39%86

--0

-95.38%86

Other non cash items

-65.77%1.87M

-86.87%680.76K

223.50%551.24K

644.23%448.45K

220.64%193.21K

2,171.05%5.47M

8,501.65%5.18M

182.76%170.4K

0.00%60.26K

Change In working capital

-104.45%-199.28K

-92.07%400.69K

6,113.01%1.04M

375.89%4.16M

-734.33%-5.81M

5,802.27%4.47M

5,922.16%5.05M

-75.64%16.8K

-246.17%-1.51M

182.52%915.2K

-Change in prepaid assets

115.59%165.67K

-14.91%92.47K

-1,755.83%-204.07K

143.04%391.03K

54.83%-113.76K

-963.68%-1.06M

14,418.31%108.68K

-101.87%-11K

-2,746.77%-908.5K

65.11%-251.84K

-Change in payables and accrued expense

-102.08%-125.48K

-93.92%308.23K

359.00%1.31M

833.62%3.86M

-562.99%-5.6M

1,641.65%6.04M

3,868.72%5.07M

159.90%284.98K

-150.61%-526.27K

450.59%1.21M

-Change in other current assets

--0

----

---423.88K

---117.39K

----

-Change in other current liabilities

-222.03%-239.47K

--0

-222.38%-60.33K

-22.08%-90.03K

-107.04%-89.1K

56.47%-74.36K

84.01%-6.88K

212.84%49.3K

-75.35%-73.75K

-2.33%-43.04K

Cash from discontinued investing activities

Operating cash flow

-30.83%-33.64M

-12.33%-8.46M

-21.77%-7.18M

18.66%-4.81M

-107.08%-13.19M

-105.91%-25.71M

-67.26%-7.53M

-14.90%-5.89M

-725.52%-5.92M

-67.51%-6.37M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-52.24%16.38M

10.92%10.77M

-96.73%802.33K

970.07%240.01K

60,902.34%4.57M

-29.87%34.29M

74,666,484.62%9.71M

19,777.64%24.55M

-99.95%22.43K

7.49K

Net issuance payments of debt

-100.24%-59.3K

---13.17K

-100.05%-12.88K

---12.59K

---20.67K

--25M

--0

--25M

--0

Net common stock issuance

63.62%16.13M

6.32%10.48M

--815.2K

--243.74K

--4.59M

-79.70%9.86M

--9.86M

--0

Proceeds from stock option exercised by employees

104.04%308.94K

146.99%300.09K

--0

-60.55%8.85K

--0

-56.00%151.42K

934,507.69%121.5K

--0

-89.83%22.43K

--7.49K

Net other financing activities

----

---720.29K

---270.96K

----

Cash from discontinued financing activities

Financing cash flow

-52.24%16.38M

10.92%10.77M

-96.73%802.33K

970.07%240.01K

60,902.34%4.57M

-29.87%34.29M

74,666,484.62%9.71M

19,777.64%24.55M

-99.95%22.43K

--7.49K

Net cash flow

Beginning cash position

13.15%73.82M

-24.27%54.25M

14.42%60.62M

10.73%65.2M

13.15%73.82M

126.23%65.24M

2.72%71.64M

-29.12%52.98M

135.17%58.88M

126.23%65.24M

Current changes in cash

-301.22%-17.26M

6.03%2.31M

-134.16%-6.37M

22.42%-4.57M

-35.51%-8.62M

-76.44%8.58M

148.38%2.18M

472.77%18.66M

-111.86%-5.9M

-67.31%-6.36M

End cash Position

-23.38%56.56M

-24.27%54.25M

14.42%60.62M

10.73%65.2M

13.15%73.82M

2.72%71.64M

-29.12%52.98M

135.17%58.88M

Free cash flow

-30.83%-33.64M

-12.33%-8.46M

-21.77%-7.18M

18.66%-4.81M

-107.08%-13.19M

-105.91%-25.71M

-67.26%-7.53M

-14.90%-5.89M

-725.52%-5.92M

-67.51%-6.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-30.83%-33.64M	-12.33%-8.46M	-21.77%-7.18M	18.66%-4.81M	-107.08%-13.19M	-105.91%-25.71M	-67.26%-7.53M	-14.90%-5.89M	-725.52%-5.92M	-67.51%-6.37M
Net income from continuing operations	-5.11%-42.94M	43.05%-10.9M	-46.13%-10.85M	-98.22%-11.53M	-14.00%-9.66M	-141.48%-40.85M	-202.81%-19.14M	-6.66%-7.42M	-888.10%-5.82M	-177.95%-8.47M
Depreciation and amortization	20,084.88%17.36K	--4.74K	--4.73K	--4.74K	3,568.60%3.16K	-98.39%86	--0	--0	--0	-95.38%86
Other non cash items	-65.77%1.87M	-86.87%680.76K	223.50%551.24K	644.23%448.45K	220.64%193.21K	2,171.05%5.47M	8,501.65%5.18M	182.76%170.4K	0.00%60.26K	0.00%60.26K
Change In working capital	-104.45%-199.28K	-92.07%400.69K	6,113.01%1.04M	375.89%4.16M	-734.33%-5.81M	5,802.27%4.47M	5,922.16%5.05M	-75.64%16.8K	-246.17%-1.51M	182.52%915.2K
-Change in prepaid assets	115.59%165.67K	-14.91%92.47K	-1,755.83%-204.07K	143.04%391.03K	54.83%-113.76K	-963.68%-1.06M	14,418.31%108.68K	-101.87%-11K	-2,746.77%-908.5K	65.11%-251.84K
-Change in payables and accrued expense	-102.08%-125.48K	-93.92%308.23K	359.00%1.31M	833.62%3.86M	-562.99%-5.6M	1,641.65%6.04M	3,868.72%5.07M	159.90%284.98K	-150.61%-526.27K	450.59%1.21M
-Change in other current assets	--0	--0	----	----	----	---423.88K	---117.39K	----	----	----
-Change in other current liabilities	-222.03%-239.47K	--0	-222.38%-60.33K	-22.08%-90.03K	-107.04%-89.1K	56.47%-74.36K	84.01%-6.88K	212.84%49.3K	-75.35%-73.75K	-2.33%-43.04K
Cash from discontinued investing activities
Operating cash flow	-30.83%-33.64M	-12.33%-8.46M	-21.77%-7.18M	18.66%-4.81M	-107.08%-13.19M	-105.91%-25.71M	-67.26%-7.53M	-14.90%-5.89M	-725.52%-5.92M	-67.51%-6.37M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-52.24%16.38M	10.92%10.77M	-96.73%802.33K	970.07%240.01K	60,902.34%4.57M	-29.87%34.29M	74,666,484.62%9.71M	19,777.64%24.55M	-99.95%22.43K	7.49K
Net issuance payments of debt	-100.24%-59.3K	---13.17K	-100.05%-12.88K	---12.59K	---20.67K	--25M	--0	--25M	--0	--0
Net common stock issuance	63.62%16.13M	6.32%10.48M	--815.2K	--243.74K	--4.59M	-79.70%9.86M	--9.86M	--0	--0	--0
Proceeds from stock option exercised by employees	104.04%308.94K	146.99%300.09K	--0	-60.55%8.85K	--0	-56.00%151.42K	934,507.69%121.5K	--0	-89.83%22.43K	--7.49K
Net other financing activities	----	----	----	----	----	---720.29K	---270.96K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-52.24%16.38M	10.92%10.77M	-96.73%802.33K	970.07%240.01K	60,902.34%4.57M	-29.87%34.29M	74,666,484.62%9.71M	19,777.64%24.55M	-99.95%22.43K	--7.49K
Net cash flow
Beginning cash position	13.15%73.82M	-24.27%54.25M	14.42%60.62M	10.73%65.2M	13.15%73.82M	126.23%65.24M	2.72%71.64M	-29.12%52.98M	135.17%58.88M	126.23%65.24M
Current changes in cash	-301.22%-17.26M	6.03%2.31M	-134.16%-6.37M	22.42%-4.57M	-35.51%-8.62M	-76.44%8.58M	148.38%2.18M	472.77%18.66M	-111.86%-5.9M	-67.31%-6.36M
End cash Position	-23.38%56.56M	-23.38%56.56M	-24.27%54.25M	14.42%60.62M	10.73%65.2M	13.15%73.82M	13.15%73.82M	2.72%71.64M	-29.12%52.98M	135.17%58.88M
Free cash flow	-30.83%-33.64M	-12.33%-8.46M	-21.77%-7.18M	18.66%-4.81M	-107.08%-13.19M	-105.91%-25.71M	-67.26%-7.53M	-14.90%-5.89M	-725.52%-5.92M	-67.51%-6.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall